117 related articles for article (PubMed ID: 37604705)
21. Corrigendum to "Mesh versus acellular dermal matrix in immediate implant-based breast reconstruction - A prospective randomized trial" [Eur J Surg Oncol 42 (5) (2016) 665-671].
Gschwantler-Kaulich D; Schrenk P; Bjelic-Radisic V; Unterrieder K; Leser C; Fink-Retter A; Salama M; Singer C
Eur J Surg Oncol; 2017 Jul; 43(7):1380-1381. PubMed ID: 28526188
[No Abstract] [Full Text] [Related]
22. Corrigendum to "Staging of oropharyngeal squamous cell carcinoma of the head and neck: Prognostic features and power of the 8th edition of the UICC staging manual" [Eur. J. Surg. Oncol. 45 (6) (2019) 1046-1053].
Beltz A; Gösswein D; Zimmer S; Limburg I; Wünsch D; Gribko A; Deichelbohrer M; Hagemann J; Stauber RH; Künzel J
Eur J Surg Oncol; 2019 Sep; 45(9):1755-1756. PubMed ID: 31307815
[No Abstract] [Full Text] [Related]
23. Checkpoint inhibitors: the new treatment paradigm for urothelial bladder cancer.
Katz H; Wassie E; Alsharedi M
Med Oncol; 2017 Sep; 34(10):170. PubMed ID: 28864844
[TBL] [Abstract][Full Text] [Related]
24. Systematic review of LHRH agonists for the adjuvant treatment of early breast cancer.
Sharma R; Beith J; Hamilton A
Breast; 2005 Jun; 14(3):181-91. PubMed ID: 15927827
[TBL] [Abstract][Full Text] [Related]
25. Factors associated with early mobilization among colorectal cancer patients after surgery: A cross-sectional study.
Xie J; Luo C; Du Q; Zou W; Li X; Ma Z; Wu X; Zhang M
Eur J Oncol Nurs; 2023 Jun; 64():102317. PubMed ID: 37187102
[No Abstract] [Full Text] [Related]
26. Corrigendum to 'Health-Promoting Lifestyle in Colorectal Cancer Survivors: A Qualitative Study on the Experiences and Perspectives of Colorectal Cancer Survivors and Healthcare Providers' [Asia-Pacific J Oncol Nursing 8 (2021) 696-710].
Ramezanzade Tabriz E; Ramezani M; Heydari A; Aledavood SA
Asia Pac J Oncol Nurs; 2022 Aug; 9(8):100106. PubMed ID: 35983241
[TBL] [Abstract][Full Text] [Related]
27. Corrigendum to "Knowledge of Opioid-induced Respiratory Depression Among Chinese Healthcare Professionals：A Cross-Sectional Study" [Asia-Pacific J Oncol Nursing 9 (2022) 55-60].
Li X; Li N; Lu Y; Ma X; Yang H; Sun H; Chen F
Asia Pac J Oncol Nurs; 2023 Mar; 10(3):100191. PubMed ID: 36820235
[TBL] [Abstract][Full Text] [Related]
28. Corrigendum to "Diagnostic Accuracy of Novel Urinary Biomarker Tests in Non-muscle-invasive Bladder Cancer: A Systematic Review and Network Meta-analysis" [Eur Urol Oncol 2021;4:927-42].
Laukhtina E; Shim SR; Mori K; D'Andrea D; Soria F; Rajwa P; Mostafaei H; Compérat E; Cimadamore A; Moschini M; Teoh JY; Enikeev D; Xylinas E; Lotan Y; Palou J; Gontero P; Babjuk M; Witjes JA; Kamat AM; Roupret M; Shariat SF; Pradere B;
Eur Urol Oncol; 2022 Aug; 5(4):480-481. PubMed ID: 35063436
[No Abstract] [Full Text] [Related]
29. Erratum to "Outcomes of the use of different vulvar flaps for reconstruction during surgery for vulvar cancer" [Eur J Surg Oncol 45 9 (2019) 1625-1631].
Tock S; Wallet J; Belhadia M; Hudry D; Ghesquière L; Narducci F; Leblanc E
Eur J Surg Oncol; 2020 Oct; 46(10 Pt A):1973. PubMed ID: 32624290
[No Abstract] [Full Text] [Related]
30. Corrigendum to "Berberine induces SOCS1 pathway to reprogram the M1 polarization of macrophages via miR-155-5p in colitis-associated colorectal cancer" [Eur. J. Pharmacol. 949 (2023) 175724].
Ling Q; Fang J; Zhai C; Huang W; Chen Y; Zhou T; Liu Y; Fang X
Eur J Pharmacol; 2023 Nov; 959():176109. PubMed ID: 37863803
[No Abstract] [Full Text] [Related]
31. Corrigendum to "Evaluating sex as a predictive marker for response to bevacizumab in metastatic colorectal carcinoma: Pooled analysis of 3369 patients in the ARCAD database" Eur J Cancer. 2023 Jan;178:162-170.
Margalit O; Harmsen WS; Shacham-Shmueli E; Voss MM; Boursi B; Wagner AD; Cohen R; Olswold CL; Saltz LB; Goldstein DA; Hurwitz H; Tebbutt NC; Kabbinavar FF; Adams RA; Chibaudel B; Grothey A; Yoshino T; Zalcberg J; de Gramont A; Shi Q; Lenz HJ
Eur J Cancer; 2023 Nov; 194():113339. PubMed ID: 37813779
[No Abstract] [Full Text] [Related]
32. Corrigendum to "RECIST 1.1, Choi and mChoi criteria in the evaluation of tumor response in patients with metastatic colorectal cancer treated with Regorafenib and anti-PD-1 antibody" [Eur. J. Radiol. 141 (2021) 109823].
Li L; Xu Y; Yang Y; Ye F; Zhang H; Zhou A; Zhao X
Eur J Radiol; 2021 Sep; 142():109897. PubMed ID: 34371308
[No Abstract] [Full Text] [Related]
33. Corrigendum to "Despite multi-disciplinary team discussions the socioeconomic disparities persist in the oncological treatment of non-metastasized colorectal cancer" [Eur J Cancer 199 (2024) 113572].
Osterman E; Syriopoulou E; Martling A; Andersson TM; Nordenvall C
Eur J Cancer; 2024 Apr; 201():113940. PubMed ID: 38383167
[No Abstract] [Full Text] [Related]
34. Corrigendum to "Effect of visceral fat area on the accuracy of preoperative CT-N staging of colorectal cancer" [Eur. J. Radiol. 168 (2023) 111131].
Xie M; Liu G; Dong Y; Yu L; Song R; Zhang W; Zhang Y; Huang S; He J; Xiao Y; Long L
Eur J Radiol; 2024 Jan; 170():111253. PubMed ID: 38159330
[No Abstract] [Full Text] [Related]
35. Corrigendum to "Design and synthesis of highly TRAIL expression HDAC inhibitors based on ONC201 to promote apoptosis of colorectal cancer" [Eur. J. Med. Chem. 238 (2022) 1-20/114484].
Cui H; Hu Z; Yang K; Huang J; Wu Y; Chen Q; Wei R; Wang P; Wang H; Li H; Chen Y; Lu T; Yao Y; Zhu Y
Eur J Med Chem; 2022 Oct; 240():114568. PubMed ID: 35809536
[No Abstract] [Full Text] [Related]
36. Erratum to "Management of the positive pathologic circumferential resection margin in rectal cancer: A national cancer database (NCDB) study" [Eur J Surg Oncol 47 (2) (February 2021) 296-303].
Reif de Paula T; Augestad KM; Kiran RP; Keller DS
Eur J Surg Oncol; 2023 Oct; 49(10):106949. PubMed ID: 37620244
[No Abstract] [Full Text] [Related]
37. Corrigendum to "Design and synthesis of novel artemisinin hybrids with potent activities against human colorectal cancer cells in vitro and in vivo" [Eur. J. Med. Chem. 182 (2019) 111665].
Wang LL; Kong L; Liu H; Zhang Y; Zhang L; Liu X; Yuan F; Li Y; Zuo Z
Eur J Med Chem; 2020 May; 194():112256. PubMed ID: 32220686
[No Abstract] [Full Text] [Related]
38. Corrigendum to "Rim enhancement on hepatobiliary phase of pre-treatment 3.0 T MRI: A potential marker for early chemotherapy response in colorectal liver metastases treated with XELOX" [Eur. J. Radiol. 143 (2021) 109887].
Wang X; Wang Y; Zhang Z; Zhou M; Zhou X; Zhao H; Xing J; Zhou Y
Eur J Radiol; 2022 Mar; 148():110154. PubMed ID: 35016131
[No Abstract] [Full Text] [Related]
39. Corrigendum to: Joint association of physical activity and body mass index with cardiovascular risk: a nationwide population-based cross-sectional study. [Eur J Prev Cardiol 2021; https://doi.org/10.1093/eurjpc/zwaa151].
Eur J Prev Cardiol; 2021 Dec; 28(14):1620-1621. PubMed ID: 34037704
[No Abstract] [Full Text] [Related]
40. Erratum to "Impact of Oncotype DX Breast Recurrence Score testing on adjuvant chemotherapy use in early breast cancer: Real world experience in Greater Manchester, UK" [Eur J Surg Oncol 43 (5) (2017) 931-937].
Bundred NJ
Eur J Surg Oncol; 2018 Jan; 44(1):194. PubMed ID: 29174199
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
